These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32830242)

  • 21. Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: towards genotype-guided antimicrobial therapy.
    Pond MJ; Hall CL; Miari VF; Cole M; Laing KG; Jagatia H; Harding-Esch E; Monahan IM; Planche T; Hinds J; Ison CA; Chisholm S; Butcher PD; Sadiq ST
    J Antimicrob Chemother; 2016 Apr; 71(4):897-902. PubMed ID: 26817487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial resistance and heterogeneity of Neisseria gonorrhoeae isolated from patients attending sexually transmitted infection clinics in Lusaka, Zambia.
    Sarenje KL; van Zwetselaar M; Kumburu H; Sonda T; Mmbaga B; Ngalamika O; Maimbolwa MC; Siame A; Munsaka S; Kwenda G
    BMC Genomics; 2024 Mar; 25(1):290. PubMed ID: 38500064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A real-time PCR assay for direct characterization of the Neisseria gonorrhoeae GyrA 91 locus associated with ciprofloxacin susceptibility.
    Buckley C; Trembizki E; Donovan B; Chen M; Freeman K; Guy R; Kundu R; Lahra MM; Regan DG; Smith H; Whiley DM;
    J Antimicrob Chemother; 2016 Feb; 71(2):353-6. PubMed ID: 26538505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-Time PCR Targeting the
    Wong LK; Hemarajata P; Soge OO; Humphries RM; Klausner JD
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848021
    [No Abstract]   [Full Text] [Related]  

  • 25. Antimicrobial resistance and molecular characterisation of Neisseria gonorrhoeae isolates in Fukuoka, Japan, 1996-2016.
    Tanaka M; Furuya R; Kobayashi I; Kanesaka I; Ohno A; Katsuse AK
    J Glob Antimicrob Resist; 2019 Jun; 17():3-7. PubMed ID: 30448519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic analysis of 1710 surveillance-based
    Reimche JL; Clemons AA; Chivukula VL; Joseph SJ; Schmerer MW; Pham CD; Schlanger K; St Cyr SB; Kersh EN; Gernert KM; Antimicrobial-Resistant Working Group
    Microb Genom; 2023 May; 9(5):. PubMed ID: 37171855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multiplex assay for characterization of antimicrobial resistance in Neisseria gonorrhoeae using multi-PCR coupled with mass spectrometry.
    Li Y; Xiu L; Liu J; Zhang C; Wang F; Yin Y; Peng J
    J Antimicrob Chemother; 2020 Oct; 75(10):2817-2825. PubMed ID: 32688393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High percentages of resistance to tetracycline and penicillin and reduced susceptibility to azithromycin characterize the majority of strain types of Neisseria gonorrhoeae isolates in Cuba, 1995-1998.
    Sosa J; Ramirez-Arcos S; Ruben M; Li H; Llanes R; Llop A; Dillon JA
    Sex Transm Dis; 2003 May; 30(5):443-8. PubMed ID: 12916137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.
    Thakur SD; Starnino S; Horsman GB; Levett PN; Dillon JR
    J Antimicrob Chemother; 2014 Jun; 69(6):1510-6. PubMed ID: 24532681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibilities and molecular typing of neisseria gonorrhoeae isolates at a medical centre in Taiwan, 2001-2013 with an emphasis on high rate of azithromycin resistance among the isolates.
    Liu YH; Huang YT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2018 May; 51(5):768-774. PubMed ID: 29477549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015-16.
    Bazzo ML; Golfetto L; Gaspar PC; Pires AF; Ramos MC; Franchini M; Ferreira WA; Unemo M; Benzaken AS;
    J Antimicrob Chemother; 2018 Jul; 73(7):1854-1861. PubMed ID: 29635367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility in
    Latif AS; Gwanzura L; Machiha A; Ndowa F; Tarupiwa A; Gudza-Mugabe M; Shukusho FD; Chakanyuka Musanhu C; Wi T; Unemo M
    Sex Transm Infect; 2018 Feb; 94(1):62-66. PubMed ID: 28476914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.
    Lewis DA; Sriruttan C; Müller EE; Golparian D; Gumede L; Fick D; de Wet J; Maseko V; Coetzee J; Unemo M
    J Antimicrob Chemother; 2013 Jun; 68(6):1267-70. PubMed ID: 23416957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neisseria gonorrhoeae antimicrobial susceptibility in Barcelona: penA, ponA, mtrR, and porB mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins.
    Serra-Pladevall J; Barberá MJ; Rodriguez S; Bartolomé-Comas R; Roig G; Juvé R; Andreu A
    Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1549-56. PubMed ID: 27255221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
    Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V;
    BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.
    Hottes TS; Lester RT; Hoang LM; McKay R; Imperial M; Gilbert M; Patrick D; Wong T; Martin I; Ogilvie G
    Sex Transm Dis; 2013 Jan; 40(1):46-51. PubMed ID: 23250301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic and Genotypic Characterization of
    Jamaludin N; Gedye K; Collins-Emerson J; Benschop J; Nulsen M
    Microb Drug Resist; 2019 Sep; 25(7):1003-1011. PubMed ID: 31021281
    [No Abstract]   [Full Text] [Related]  

  • 38. Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae.
    Donà V; Low N; Golparian D; Unemo M
    Expert Rev Mol Diagn; 2017 Sep; 17(9):845-859. PubMed ID: 28741392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiplex Real-Time PCR Assay with High-Resolution Melting Analysis for Characterization of Antimicrobial Resistance in Neisseria gonorrhoeae.
    Donà V; Kasraian S; Lupo A; Guilarte YN; Hauser C; Furrer H; Unemo M; Low N; Endimiani A
    J Clin Microbiol; 2016 Aug; 54(8):2074-81. PubMed ID: 27225407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.
    Cole MJ; Quinten C; Jacobsson S; Day M; Amato-Gauci AJ; Woodford N; Spiteri G; Unemo M;
    BMC Infect Dis; 2019 Dec; 19(1):1040. PubMed ID: 31822275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.